Cargando…
Doxorubicin selectively induces apoptosis through the inhibition of a novel isoform of Bcl-2 in acute myeloid leukaemia MOLM-13 cells with reduced Beclin 1 expression
The overexpression of anti-apoptotic Bcl-2 in acute myeloid leukaemia (AML) may contribute to difficulties in eradicating these cells during chemotherapy. In the present study, doxorubicin (Dox) was evaluated for its potential to induce selective apoptotic cell death in AML MOLM-13 cells and to modu...
Autores principales: | Vu, Milan, Kassouf, Nick, Ofili, Rosemary, Lund, Torben, Bell, Celia, Appiah, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252449/ https://www.ncbi.nlm.nih.gov/pubmed/32377726 http://dx.doi.org/10.3892/ijo.2020.5052 |
Ejemplares similares
-
Betulinic Acid–Doxorubicin-Drug Combination Induced Apoptotic Death via ROS Stimulation in a Relapsed AML MOLM-13 Cell Model
por: Vu, Milan, et al.
Publicado: (2021) -
Establishment and characterization of hypomethylating agent-resistant cell lines, MOLM/AZA-1 and MOLM/DEC-5
por: Hur, Eun-Hye, et al.
Publicado: (2016) -
Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the acute myeloid leukemia cell line MOLM-13
por: Prajapati, Subhash C, et al.
Publicado: (2022) -
Regulation of the Autophagic Bcl-2/Beclin 1 Interaction
por: Decuypere, Jean-Paul, et al.
Publicado: (2012) -
Changes in Apoptotic Pathways in MOLM-13 Cell Lines after Induction of Resistance to Hypomethylating Agents
por: Janotka, Ľuboš, et al.
Publicado: (2021)